Business
KDA Group Has Signed A Letter of Intent for the Acquisition of Consultandgrow
(via TheNewswire) Thetford Mines, Quebec - TheNewswire - August 7, 2019 - KDA Gr...

About this update from Kda Group Inc.
[{"type":"text","content":"KDA Group Has Signed A Letter of Intent for the Acquisition of Consultandgrow(via TheNewswire)\n \n \n\n\n \n \nThetford Mines, Quebec - TheNewswire - August 7, 2019 - KDA Group Inc. (TSXV:KDA) (\"KDA\" or the \"Corporation\") is proud to announce that it has signed a letter of intent (\"LOI\") with the shareholders of Consultandgrow Inc. (the \"Shareholders\") on August 6, 2019 for the purchase of all the shares of Consultandgrow Inc. (\"Consultandgrow\").\n\n\n \nConsultandgrow is a Canadian private corporation that provides expert-consulting services and turnkey solutions for a fast and efficient obtaining of cannabis and hemp licenses in Canada, both federally and provincially, for commercial, recreational and/or medical purposes. In addition to its services and solutions with regard to the obtaining of the licenses, Consultandgrow is also recognized for its consulting, compliance and solution services with respect to strategies, management and operations related to cannabis and hemp cultivation, processing and distribution. Since 2017, the Consultandgrow team has worked on more than 40 cannabis cultivation, processing and sale projects across Canada. The experts constituting the Consultandgrow team hold the appropriate know-how in all the important aspects to facilitate and ensure the fast obtaining of a license and the efficient launching of the operations. Totaling more than one million square feet of cannabis cultivation, one million square feet of hemp cultivation and several cannabis processing sites, the Consultandgrow network offers an abundance of solutions and services such as analysis, supply of biomass, processing into finished products and global distribution.\n\n\n \nConsultandgrow integrates directly into KDA's corporate strategy to become an essential reference for any participant and patient regarding cannabis products and services for medical purposes.\n\n\n \n\"This potential acquisition will enable us as a group to support our ongoing and future cannabis projects and ensure the compliance of our operations and facilities with the Good Manufacturing Practices (GMP) certification and GMP Europe for future export,\" explains Marc Lemieux, President and Chief Executive Officer of KDA.\n\n\n \nKDA has agreed to acquire all of the issued and outstanding common shares of Consultandgrow for an aggregate price of ...